Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents.
Fiche publication
Date publication
avril 2022
Journal
Journal of the American Geriatrics Society
Auteurs
Membres identifiés du Cancéropôle Est :
Dr JEULIN Hélène
Tous les auteurs :
Jeulin H, Labat C, Duarte K, Toupance S, Nadin G, Craus D, Georgiopoulos I, Gantois I, Goehringer F, Benetos A
Lien Pubmed
Résumé
Duration of post-vaccination protection against COVID-19 in nursing home (NH) residents is a critical issue. The objective of this study was to estimate the duration of the IgG(S) response to the mRNA BNT162b2 vaccine in NH residents with (COV-Yes) or without (COV-No) history of SARS-CoV-2 infection.
Mots clés
SARS-CoV-2, nursing homes, vaccination
Référence
J Am Geriatr Soc. 2022 Apr 29;: